Crystal forms of immunomodulators
US11939306B2 · kind B2 · utility
2Cited by
16References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 25, 2023 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jan 25, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to crystalline forms of a 3-substituted 1,2,4-oxadiazole compound, including an anhydrous crystalline form, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for pharmaceutical, veterinary, and agriculturally-relevant uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.